Small changes in ambient temperature cause large changes in 3,4- methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat

Journal of Neuroscience

Volumn 18, Issue 13, 1998, Pages 5086-5094

  Malberg, Jessica E ^a   Seiden, Lewis S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

5 HT; Ambient temperature; Amphetamine; Core body temperature; MDMA; Neurotoxicity; Thermoregulation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORE TEMPERATURE; CORPUS STRIATUM; DRUG ABUSE; ENVIRONMENTAL TEMPERATURE; FRONTAL CORTEX; HIPPOCAMPUS; HYPERTHERMIA; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SOMATOSENSORY CORTEX; THERMOREGULATION;

EID: 0032125256     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-13-05086.1998     Document Type: Article

References (66)

1. Ainsworth AM, Malberg JE, Seiden LS (1997) High and low doses of 3,4-methylenedioxymethamphetamine (MDMA) impair thermoregulatory ability in the rat. Soc Neurosci Abstr 2:1352.
2. Ali SF, Newport GD, Holson RR, Slikker Jr W, Bowyer JF (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
3. Ames D, Wirshing WC (1993) Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome-a possible link [letter]? JAMA 269:869-870.
4. Battaglia G, Yeh SY, DeSouza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274.
5. Bowyer JF, Tank AW, Newport GD, Slikker Jr W, Ali SF, Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824.
6. Bowyer JF, Gough B, Slikker Jr W, Lipe GW, Newport GD, Holson RR (1993) Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol Biochem Behav 44:87-98.
7. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker Jr W, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268: 1571-1580.
8. Busto R, Dietrich WD, Globus MYT, Valdes I, Scheinberg P, Ginsberg MD (1987) Small differences in intraischmic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 7:729-738.
9. Cadet JL, Ali S, Epstein C (1994) Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice. Ann NY Acad Sci 738:388-391.
10. Cardell M, Boris-Moller F, Wieloch T (1991) Hypothermia prevents the ischemia-induced translocations and inhibition of protein kinase C in the rat striatum. J Neurochem 57:1814-1817.
11. Carlsson A (1993) Search for the neuronal circuitries and heurotransmitters involved in "positive" and "negative" schizophrenic symptomatology. Fidia Res Found Lect Ser 7.
12. Che S, Johnson M, Hanson GR, Gibb JW (1995) Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur J Pharmacol 293:447-453.
13. Clausing P, Bloom D, Newport GD, Holson RR, Slikker Jr W, Bowyer JF (1996) Individual differences in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putamen in unlesioned rats. Psychopharmacology 127:187-194.
14. Clement JG, Mills P, Brockway B (1989) Use of telemetry to record body temperature and activity in mice. J Pharmacol Methods 21:129-140.
15. Colado MI, Murray TK, Green AR (1993) 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br J Pharmacol 108:583-589.
16. Colado MI, Williams JL, Green AR (1995) The hyperthermic and neurotoxic effects of "Ecstasy" (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 115:1281-1289.
17. Commins DL, Axt KJ, Vosmer G, Seiden LS (1987a) 5,6-Dihydroxytryptamine, a serotonergic neurotoxin is formed endogenously in the rat brain. Brain Res 403:7-14.
18. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987b) Biochemical and histological evidence that meth- ylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338-345.
19. Corbett D, Evans S, Thomas C, Wang D, Jonas R A (1990) MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res 514:300-304.
20. Dafters RI (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology 114:505-508.
21. Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption and chronic dosing. Physiol Behav 58:877-882.
22. Dar KJ, McBrien ME (1996) MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med 22: 995-996.
23. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13:2651-2661.
24. Dilsaver SC, Majchrzak MJ, Alessi NE (1990) Telemetric measurement of core temperature in pharmacological research: validity and reliability. Prog Neuro-Psychopharmacol Biol Psychiatry 14:591-596.
25. Dilsaver SC, Overstreet DH, Peck JA (1992) Measurement of temperature in the rat by rectal probe and telemetry yields compatible results. Pharmacol Biochem Behav 42:549-552.
26. Farfel GM, Seiden LS (1995a) Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS19755 and NBQX. J Pharmacol Exp Ther 272:860-867.
27. Farfel GM, Seiden LS (1995b) Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine. p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J Pharmacol Exp Ther 272:868-875.
28. Friedman R (1993) Ecstasy, the serotonin syndrome, and malignant hyperthermia-a possible link [reply to letter]? JAMA 269:269-270.
29. Ginsberg MD, Sternau LL, Gloms MY, Dietrich WD, Busto R (1992) Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc Brain Metab Rev 4:189-225.
30. Globus MY, Busto R, Lin B, Schnippering H, Ginsberg MD (1995) Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J Neurochem 65:1250-1256.
31. Gordon CJ (1993) Temperature regulation in laboratory animals. New York: Cambridge UP.
32. Gordon CJ, Fogelson L (1994) Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: implications for pharmacological studies. Physiol Behav 56:73-79.
33. Gordon CJ, Watkinson WP. O'Callaghan JP, Miller DB (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 38:339-344.
34. Green AR, Cross AJ, Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacology 119:247-260.
35. Gudelsky GA (1996) Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin. J Neural Transm 103:1397-1404.
36. Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623.
37. Henry JA (1992) Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 340:384-387.
38. Illievich UM, Zornow MH, Choi KT, Strnat MA, Sehcller MS (1994) Effects of hypothermia or anesthetics on hippocampal glutamate and glycine concentrations after repeated transient global cerebral ischemia. Anesthesiology 80:177-186.
39. Kaskey GB (1992) Possible interaction between an MAOI and "Ecstasy." Am J Psychiatry 149:411-412.
40. Kil HY, Zhang J, Piantadosi CA (1996) Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J Cereb Blood Flow Metab 16:100-106.
41. Kotake C, Heffner T, Vosmer G, Seiden LS (1985) Determination of dopamine, norepinephrine, serotonin and their major metabolic products in rat brain by reverse phase ion pair high performance liquid chromatography with electrochemical detection. Pharmacol Biochem Behav 22:85-89.
42. Kramer HK, Poblete JC, Azmitia EC (1995) 3,4-methylenedioxymethamphetamine ("Ecstasy") promotes the translocation of protein kinase C (PKC): requirement of viable serotonin nerve terminals. Brain Res 680:1-8.
43. Kramer HK, Poblete JC, Azmitia EC (1997) Activation of protein kinase C (PKC) by 3,4-methylenudioxymelhamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter. Neuropsychophannacology 17:117-129.
44. Lew R, Sabol KE, Chou C, Vosmer GL, Richards J, Seiden LS (1996) Methylenedioxymethamphetamine (MDMA)-induced serotonin deficits are followed by partial recovery over a 52 week period. II. Radio-ligand binding and autoradiographic studies. J Pharmacol Exp Ther 276:855-865.
45. Malberg JE, Seiden LS (1996) 3,4-methylenedioxymethamphetamine (MDMA) 5HT neurotoxicity is a function of ambient temperature and core body temperature in rats. Soc Neurosci Abstr 3:1916.
46. Malberg JE, Sabol KE, Seiden LS (1996) Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278:258-267.
47. Mazzola-Pomietto P, Aulakh CS, Tolliver T, Murphy DL (1997) Functional subsensitivity to 5HT2A and 5HT2C receptors mediating hyperthermia following acute and chronic treatment with 5HT2A/2C receptor agonists. Psychopharmacology 130:144-151.
48. McCann UD, Slate SO, Ricaurte GA (1996) Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"). Drug Saf 15:107-115.
49. Miller DB, O'Callaghan JP (1994) Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
50. Mitani A, Kadoya F, Kataoka K (1991) Temperature dependence of hypoxia-induced calcium accumulation in gerbil hippocampal slices. Brain Res 562:159-163.
51. Nash JF, Meltzer HY, Gudelsky GA (1988) Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245:873-879.
52. Nash JF, Roth BL, Brodki JD, Nichols DE, Gudelsky GA (1994) Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphotidylinositol turnover in cultured cells expressing 5HT2A and 5HT2C receptors. Neurosci Lett 177:111-115.
53. O'Hearn E, Battaglia G, DeSouza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803.
54. Rudnick G, Wall SC (1992) The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817-1821.
55. Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS (1996) Methylenedioxymethamphetamine (MDMA)-induced serotonin deficits are followed by partial recovery over a 52 week period. I. Synaptosomal uptake and tissue concentrations. J Pharmacol Exp Ther 276:846-854.
56. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7.
57. Schmidt CJ, Wu L, Lovenberg W (1986) Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. Eur J Pharmacol 124:175-178.
58. Seiden LS, Vosmer G (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol Biochem Behav 21:29-31.
59. Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243:398-400.
60. Spanos LJ, Yamamoto BK (1989) Acute and subchronic effccts of methylenedioxymethamphetamine [(±) MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav 32:835-840.
61. Sporer KA (1995) The serotonin syndrome. Drug Saf 13:94-104.
62. Steele TD, McCann UD, Ricaurte GA (1994) 3,4-Methylenedioxymethamphetamine (MDMA; "Ecstasy"): pharmacology and toxicology in animals and humans [review]. Addiction 89:539-551.
63. Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148:705-713.
64. Stone DM, Johnson M, Hanson GR, Gibb JW (1988) Role of endogenous dopaminc in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 247:79-87.
65. Wilkinson LO, Auerbach SB, Jacobs BL (1991) Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia. J Neurosci 11:2732-2741.
66. Zeevalk GD, Nicklas WJ (1993) Hypothermia, metabolic stress and NMDA-mediated excitotoxicity. J Neurochem 61:1445-1453.